Clinical Trial Details

Trial ID: L0930
Source ID: NCT01696487
Associated Drug: Fructose
Title: Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study.
Acronym: --
Status: Not recruiting
Study Results: No Results Available
Results: --
Conditions: Non-alcoholic Fatty Liver Disease;Non-alcoholic Steatohepatitis
Interventions: Dietary Supplement: High oral Fructose challenge (150g per day for 28 days)
Outcome Measures: Gaps per 1000 intestinal epithelial cells assessed by confocal laser endomicroscopy;Gaps per 1000 intestinal epithelial cells assessed by confocal laser endomicroscopynan
Sponsor/Collaborators: Medical University of Vienna
Gender: All
Age: 18 Years85 Years
Phases: Not applicable
Enrollment: 10
Study Type: Interventional
Study Designs: Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Start Date: 01/09/2012
Completion Date: --
Results First Posted: --
Last Update Posted: 6 October 2015
Locations: Austria
URL: https://clinicaltrials.gov/show/NCT01696487